Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.180
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.190
+0.010 (0.24%)
After-hours: Dec 5, 2025, 5:41 PM EST
Tvardi Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -23.65 | -29.4 | -17.35 | -20.54 |
| Depreciation & Amortization | 0.1 | 0.1 | 0.1 | 0.09 |
| Loss (Gain) From Sale of Investments | -0.17 | - | -0.19 | -0.36 |
| Stock-Based Compensation | 1.13 | 0.32 | 0.31 | 0.25 |
| Other Operating Activities | -5.11 | 2.04 | 0.05 | 0.03 |
| Change in Accounts Payable | 5.53 | 5.57 | -1.01 | 2.2 |
| Change in Other Net Operating Assets | -0.47 | 3.07 | -2.95 | 0.47 |
| Operating Cash Flow | -22.65 | -18.31 | -21.04 | -17.87 |
| Capital Expenditures | - | - | - | -0.05 |
| Investment in Securities | -15.08 | - | 22.47 | -21.95 |
| Investing Cash Flow | -15.08 | - | 22.47 | -22 |
| Long-Term Debt Issued | - | 28.3 | - | - |
| Net Debt Issued (Repaid) | 28.3 | 28.3 | - | - |
| Issuance of Common Stock | 0.53 | 0.01 | 0 | 0 |
| Other Financing Activities | 20.88 | -1.3 | - | - |
| Financing Cash Flow | 49.71 | 27 | 0 | 0 |
| Net Cash Flow | 11.98 | 8.7 | 1.43 | -39.86 |
| Free Cash Flow | -22.65 | -18.31 | -21.04 | -17.92 |
| Free Cash Flow Per Share | -2.38 | -2.86 | -3.30 | -2.81 |
| Levered Free Cash Flow | -12.51 | -6.91 | -15.13 | - |
| Unlevered Free Cash Flow | -12.51 | -6.91 | -15.13 | - |
| Change in Working Capital | 5.06 | 8.64 | -3.96 | 2.67 |
Source: S&P Capital IQ. Standard template.
Financial Sources.